Search results
FDA grants orphan drug status to tafenoquine for babesiosis By Investing.com
Investing.com· 3 days agoThe U.S. Food and Drug Administration (FDA) has awarded orphan drug designation to 60 Degrees ...
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 24 hours agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 15 hours agoAccording to GlobalData’s analysts, atopic dermatitis presents a mine of opportunities, particularly...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 22 hours agoThe latest development comes after AstraZeneca‘s supplemental new drug application for Tagrisso...
Supreme Court Upholds Access to Abortion Pill
Verywell Health via Yahoo News· 10 hours agoDanco Laboratories, the manufacturer of Mifeprex, applauded the court’s decision. “[The judges] maintained the stability of the FDA drug approval...
Supreme Court rejects bid to restrict access to abortion pill
TODAY via Yahoo News· 5 hours agoAbortion is effectively banned altogether in 14 states, according to the Guttmacher Institute, a...
Supreme Court rules in abortion medication case, finds group lacked standing to challenge FDA...
Fox News via Yahoo News· 17 hours agoThe Supreme Court on Thursday ruled that challengers the FDA's approval process of the abortion drug...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 5 hours agoAs a result, you lose even more weight than tirzepatide.” Retatrutide is still in Phase 3 trials and...
The Latest | The US Supreme Court rules to preserve access to the abortion pill mifepristone
Associated Press via Yahoo News· 16 hours agoThe U.S. Supreme Court on Thursday ruled unanimously to preserve access to the drug most commonly...
Ultragenyx wins surrogate endpoint debate, securing green light to seek FDA approval of gene therapy
FierceBiotech· 21 hours agoUltragenyx Pharmaceutical's work to get the FDA to recognize a biomarker as a surrogate endpoint looks to have paid off. With the agency agreeing the biomarker ...
